Edition:
India

Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329.SS)

600329.SS on Shanghai Stock Exchange

15.16CNY
23 Jan 2018
Change (% chg)

¥-0.06 (-0.39%)
Prev Close
¥15.22
Open
¥15.20
Day's High
¥15.28
Day's Low
¥15.11
Volume
1,376,994
Avg. Vol
2,459,634
52-wk High
¥19.98
52-wk Low
¥14.70

Chart for

About

TIANJIN ZHONGXIN PHARMACEUTICAL GROUP CORPORATION LIMITED is a China-based company mainly engaged in the development, manufacture and distribution of pharmaceutical products. The Company’s main products include Chinese patent medicines, western medicines, Chinese medicinal materials, pharmaceutical raw materials and preparations... (more)

Overall

Beta: 0.88
Market Cap(Mil.): ¥11,135.43
Shares Outstanding(Mil.): 768.87
Dividend: 0.15
Yield (%): 1.47

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.62
EPS (TTM): -- -- --
ROI: -- 14.89 10.61
ROE: -- 16.37 14.21

BRIEF-Tianjin Zhongxin Pharmaceutical Announces Investment Product Agreements With China Bohai Bank

Jan 8 Tianjin Zhongxin Pharmaceutical Group Corp Ltd:

08 Jan 2018

BRIEF-Tianjin Zhongxin Pharmaceutical Group Corp Says Approved RMB355 Mln Investment To Set Up Unit

Dec 26 Tianjin Zhongxin Pharmaceutical Group Corp Ltd:

26 Dec 2017

BRIEF-Tianjin Zhongxin Pharmaceutical Group appoints Li Li Qun as chairman​

Oct 10 Tianjin Zhongxin Pharmaceutical Group Corp Ltd

10 Oct 2017

BRIEF-Tianjin Zhongxin Pharma's chairman and general manager resigns due to change in job role

Aug 24 Tianjin Zhongxin Pharmaceutical Group Corp Ltd

24 Aug 2017

BRIEF-Tianjin Zhongxin Pharma's H1 net profit up 7.3 pct y/y

Aug 14 Tianjin Zhongxin Pharmaceutical Group Corp Ltd

14 Aug 2017

Earnings vs. Estimates